Oculis Holding AG (NASDAQ:OCSAW) Sees Significant Increase in Short Interest

Oculis Holding AG (NASDAQ:OCSAW) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 17,410 shares, a growth of 111.0% from the September 30th total of 8,251 shares. Based on an average daily trading volume, of 6,891 shares, the days-to-cover ratio is presently 2.5 days.

Oculis Price Performance

Shares of OCSAW stock remained flat at $2.45 on Friday. Oculis has a twelve month low of $2.01 and a twelve month high of $22.64. The stock’s 50-day moving average price is $3.30 and its 200-day moving average price is $9.75.

Oculis Company Profile

Oculis is a clinical-stage biopharmaceutical company focused on developing innovative ophthalmic treatments. The company uses its proprietary OPTIREACH technology platform to develop eye-drop formulations designed to deliver medicines to tissues at the back of the eye, potentially addressing conditions that traditionally require injections or other invasive procedures.

Oculis’ development portfolio has included treatments for retinal diseases, glaucoma and ocular surface disorders. Its investigational products have targeted conditions such as diabetic macular edema, dry eye disease and neurodegenerative eye diseases.